Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?

Author:

Mégarbane Bruno1ORCID,Scherrmann Jean‐Michel2

Affiliation:

1. Department of Medical and Toxicological Critical CareLariboisière Hospital, Federation of Toxicology APHPUniversity of Paris INSERM UMRS‐1144 Paris France

2. Faculty of PharmacyUniversity of Paris INSERM UMRS‐1144 Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID‐19 patients with at least a six‐day follow up: A pilot observational study [published online ahead of print April 11, 2020];Gautret P;Travel Med Infect Dis

2. ChenZ HuJ ZhangZ et al.Efficacy of hydroxychloroquine in patients with COVID‐19: results of a randomized clinical trial.https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v2.full.pdf. Accessed April 28 2020.

3. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease‐19 (COVID‐19);Chen J;J Zhejiang Univ (Med Sci),2020

4. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID‐19 infection [printed online ahead of print March 30, 2020];Molina JM;Med Mal Infect

5. MagagnoliJ NarendranS PereiraF CummingsT HardinJW SuttonSS AmbatiJ.Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid‐19.https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v1.article-metrics. Accessed April 28 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3